Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | Protagonist Therapeutics, Inc | MOLINA ARTURO MD
(Chief Medical Officer) |
S | Common Stock | D | 1906 | $40.98 - $40.98 | $78,107 |
| 2024-09-11 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
S | Common Stock | D | 14203 | $44.47 - $44.59 | $631,871 |
| 2024-09-11 | Protagonist Therapeutics, Inc | Ali Asif
(Chief Financial Officer) |
M | Common Stock | A | 12000 | $12.17 - $19.19 | $188,160 |
| 2024-09-10 | Protagonist Therapeutics, Inc | Waddill William D.
(Director) |
S | Common Stock | D | 8000 | $45.00 - $45.00 | $360,000 |
| 2024-09-10 | Protagonist Therapeutics, Inc | Waddill William D.
(Director) |
M | Common Stock | A | 8000 | $12.88 - $12.88 | $103,040 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |